Opko Health (OPK) Cash from Discontinued Operations (2010 - 2012)
Opko Health's (OPK) quarterly Cash from Discontinued Operations came in at 7000.0 in Q4 2012, up 97.51% YoY from 3544.14 in Q1 2012, and down 107.29% on a QoQ basis from 96000.0 in Q3 2012.
Opko Health (OPK) Cash from Discontinued Operations (2010 - 2012) Analysis & Trends
Opko Health (OPK) has 3 years of Cash from Discontinued Operations data on file, last reported at 7000.0 in Q4 2012.
- Quarterly Cash from Discontinued Operations rose 97.51% year-over-year to 7000.0 in Q4 2012, while the trailing twelve-month figure through Dec 2013 was 89000.0 (up 1171.43% YoY) and the FY2012 annual result came in at 7000.0, up 100.15% from the prior year.
- Cash from Discontinued Operations eased to 7000.0 in Q4 2012, from 96000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 96000.0 in Q3 2012 to a low of 1589000.0 in Q3 2011.
- A 3-year average of 575555.56 and a median of 281000.0 in 2011 frame the typical range for Cash from Discontinued Operations.
- Annual changes were most pronounced in 2011 — Cash from Discontinued Operations soared 55.11% — and 2012, when it soared 106.04%.
- Tracing OPK's Cash from Discontinued Operations over 3 years: stood at 626000.0 in 2010, then soared by 55.11% to 281000.0 in 2011, then soared by 97.51% to 7000.0 in 2012.
- The last three Cash from Discontinued Operations figures came in at 7000.0 (Q4 2012), 96000.0 (Q3 2012), and 157000.0 (Q2 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discont. Ops (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Opko Health | 1.13 Bn | 824.59 Mn | 80.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -7,000.00 |
| Dec 31, 2012 | -7,000.00 |
| Sep 30, 2012 | 96,000.00 |
| Sep 30, 2012 | 96,000.00 |
| Jun 30, 2012 | -157,000.00 |
| Jun 30, 2012 | -157,000.00 |
| Mar 31, 2012 | 75,000.00 |
| Mar 31, 2012 | 75,000.00 |
| Dec 31, 2011 | -281,000.00 |
| Dec 31, 2011 | -281,000.00 |
| Sep 30, 2011 | -1.59 Mn |
| Sep 30, 2011 | -1.59 Mn |
| Jun 30, 2011 | -1.11 Mn |
| Jun 30, 2011 | -1.11 Mn |
| Mar 31, 2011 | -1.59 Mn |
| Mar 31, 2011 | -1.59 Mn |
| Dec 31, 2010 | -626,000.00 |
| Dec 31, 2010 | -626,000.00 |